Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 3, 2011, Pages 247-253

  Gigante, Paul R ^a   Kotchetkov, Ivan S ^a   Kellner, Christopher P ^a   Haque, Raqeeb ^a   Ducruet, Andrew F ^a   Hwang, Brian Y ^a   Solomon, Robert A ^a   Heyer, Eric J ^a   Connolly, E Sander ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

AGED; ALLELE; APTITUDE TEST; ARTICLE; CAROTID ENDARTERECTOMY; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NEUROCOGNITIVE DYSFUNCTION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 79951810138     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.211144     Document Type: Article

References (44)

1. Heyer E, Adams D, Solomon R, et al. Neuropsychometric changes in patients after carotid endarterectomy. Stroke 1998;29:1110-15. (Pubitemid 28265463)
2. Heyer E, Sharma R, Rampersad A, et al. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol 2002;59:217-22. (Pubitemid 34240937)
3. Mocco J, Wilson D, Komotar R, et al. Predictors of neurocognitive decline after carotid endarterectomy. Neurosurgery 2006;58:844-50.
4. Hirooka R, Ogasawara K, Sasaki M, et al. Magnetic resonance imaging in patients with cerebral hyperperfusion and cognitive impairment after carotid endarterectomy. J Neurosurg 2008;108:1178-83. (Pubitemid 351798494)
5. Heyer E, Wilson D, Sahlein D, et al. APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology 2005;65:1759-63.
6. Yocum G, Gaudet J, Lee S, et al. Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy. Stroke 2009;40:1597-603.
7. Ducruet AF, Hassid BG, Mack WJ, et al. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. J Cereb Blood Flow Metab 2008;28:1048-58. (Pubitemid 351589644)
8. Kim GH, Mocco J, Hahn DK, et al. Protective effect of c5a receptor inhibition after murine reperfused stroke. Neurosurgery 2008;63:125-6.
9. Poznansky M, Clissold P, Lachmann P. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3. J Immunol 1989;143:1254-8. (Pubitemid 19211356)
10. Boon C, van de Kar N, Klevering B, et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol 2009;46:1573-94.
11. Lezak MD. Neuropsychological Assessment. 4th edn. Oxford: Oxford University Press, 2004.
12. Monk T, Weldon B, Garvan C, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008;108:18-30.
13. de Jong F, Ikram M, Despriet D, et al. Complement factor H polymorphism, inflammatory mediators, and retinal vessel diameters: the Rotterdam Study. Invest Ophthalmol Vis Sci 2007;48:3014-18. (Pubitemid 351261141)
14. Newman MF, Mathew JP, Grocott HP, et al. Central nervous system injury associated with cardiac surgery. Lancet 2006;368:694-703. (Pubitemid 44223696)
15. Mocco J, Mack W, Ducruet A, et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 2006;99:209-17. (Pubitemid 44297045)
16. Komotar RJ, Starke RM, Arias EJ, et al. The complement cascade: new avenues in stroke therapy. Curr Vasc Pharmacol 2009;7:287-92.
17. van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: Roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 2003;992:56-71. (Pubitemid 36706637)
18. Mocco J, Wilson DA, Komotar RJ, et al. Alterations in plasma complement levels after human ischemic stroke. Neurosurgery 2006;59:28-33.
19. Mack WJ, Ducruet AF, Hickman ZL, et al. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007;61:260-1.
20. Arvilommi H. Capacity of complement c3 phenotypes to bind on to mononuclear cells in man. Nature 1974;251:740-1.
21. Bartok I, Walport MJ. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3. J Immunol 1995;154:5367-75.
22. Welch TR, Beischel L, Kleesattel A. Functional consequences of the genetic polymorphism of the third component of complement. J Pediatr 1990;116:S92-7.
23. Rambausek M, van den Wall Bake A, Schumacher-Ach R, et al. Genetic polymorphism of C3 and BF in IGA nephropathy. Nephrol Dial Transplant 1987;2:208-11. (Pubitemid 18004807)
24. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of agerelated macular degeneration. N Engl J Med 2007;357:553-61. (Pubitemid 47236280)
25. Finn JE, Zhang L, Agrawal S, et al. Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994;9:1564-7. (Pubitemid 24344770)
26. Elmgreen J, Sørensen H, Berkowicz A. Polymorphism of complement c3 in chronic inflammatory bowel disease. Predominance of the c3f gene in Crohn's disease. Acta Med Scand 1984;215:375-8.
27. Ostergaard J, Bruun-Petersen G, Kristensen B. The C3-F gene in patients with intracranial saccular aneurysms. Acta Neurol Scand 1986;74:356-9. (Pubitemid 17215191)
28. Csaszar A, Duba J, Melegh B, et al. Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived mycardial infarction. Exp Clin Immunogenet 2001;18:206-12. (Pubitemid 34212076)
29. Szamosi T, Mihai K, Peto J, et al. Potential markers of the atherosclerotic process in high-risk childern. Clin Biochem 1991;24:185-7.
30. Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in agerelated macular degeneration. Retina 2007;27:269-75. (Pubitemid 46398891)
31. Volcik K, Ballantyne C, Braun M, et al. Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens 2008;21:533-8. (Pubitemid 351589664)
32. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
33. Mooijaart S, Koeijvoets K, Sijbrands E, et al. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large. Exp Gerontol 2007;42:1116-22. (Pubitemid 47633456)
34. Newman S, Stygall J, Hirani S, et al. Postoperative cognitive dysfunction after noncardiac surgery: A systematic review. Anesthesiology 2007;106:572-90. (Pubitemid 46662224)
35. Steinmetz J, Christensen K, Lund T, et al. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology 2009;110:548-55.
36. Ferro J. Hyperacute cognitive stroke syndromes. J Neurol 2001;248:841-9. (Pubitemid 32955667)
37. Mesulam M. Spatial attention and neglect: Parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events. Philos Trans R Soc Lond B Biol Sci 1999;354:1325-46. (Pubitemid 29400909)
38. Seitsonen SP, Onkamo P, Peng G, et al. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One 2008;3:e3833.
39. Anon. Potentia Pharmaceuticals I: Safety of Intravitreal POT-4 Therapy for Patients with Neovascular Age-Related Macular Degeneration. Bethesda, MD: National Library of Medicine (US), 2008, NCT00473928.
40. Heyer EJ, DeLaPaz R, Halazun HJ, et al. Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery 2006;58:474-80.
41. Wilson DA, Mocco J, D'Ambrosio AL, et al. Post-carotid endarterectomy neurocognitive decline is associated with cerebral blood flow asymmetry on post-operative magnetic resonance perfusion brain scans. Neurol Res 2008;30:302-6. (Pubitemid 351769427)
42. Ferguson G, Eliasziw M, Barr H, et al. The North American symptomatic carotid endarterectomy trial: Surgical results in 1415 patients. Stroke 1999;30:1751-8. (Pubitemid 29411810)
43. Halm E, Chassin M, Tuhrim S, et al. Revisiting the appropriateness of carotid endarterectomy. Stroke 2003;34:1464-71. (Pubitemid 36693518)
44. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and tia risk in patients with carotid artery stenosis and occlusion. Brain 2001;124:457-67. (Pubitemid 32221313)